Is there causal evidence that obstructive sleep apnea and chronic rhinitis can cause secondary migraines?

Is There Causative Evidence for Migraines Secondary to OSA and Rhinitis?

Yes, there is emerging causal evidence that obstructive sleep apnea (OSA) can cause migraine with aura, and strong associative evidence linking both OSA and chronic rhinitis to migraine, though the causal pathways differ between these conditions.

OSA and Migraine: Causal Evidence

The most recent and highest quality evidence comes from a 2025 Mendelian randomization study that provides preliminary causal evidence that OSA increases the risk of migraine with aura 1. This genetic epidemiology approach suggests OSA causally contributes to migraine with aura (OR = 1.147; 95% CI = 1.016-1.295), which was further confirmed with multivariable analysis (OR = 1.184,95% CI = 1.028-1.364). Importantly, the reverse direction (migraine causing OSA) was not supported when adjusted for confounders.

Supporting this causal relationship, a large 2025 US population-based cohort study of nearly 400,000 participants found that patients with OSA have an 85% increased risk of developing incident migraine (HR 1.85; 95% CI 1.79-1.90) 2. This association remained consistent across sex, age, race, and BMI categories, suggesting a robust relationship independent of common confounders.

Clinical Implications for OSA-Migraine Link

The evidence strongly supports routine OSA screening in patients with chronic migraine before initiating expensive biologic therapies like CGRP monoclonal antibodies 3. OSA treatment with CPAP is relatively inexpensive, widely available, and addresses a reversible comorbidity that significantly contributes to migraine-related disability through sleep fragmentation and daytime fatigue.

Established guidelines recognize this relationship: the 2007 asthma management guidelines note that OSA should be considered in patients with poorly controlled conditions, particularly those who are overweight or obese, and that accurate diagnosis is important 4. The 2008 rhinitis guidelines explicitly state that formal evaluation for OSA may be considered in adults presenting with chronic rhinitis and other risk factors associated with sleep-disordered breathing 5.

Chronic Rhinitis and Migraine: Associative Evidence

For chronic rhinitis, the evidence is primarily associative rather than causal:

• A 2026 meta-analysis found that allergic rhinitis is associated with a 2.75-fold increased risk of migraine (OR = 2.75; 95% CI, 1.80-4.19), translating to 23-82 excess migraine cases per 1,000 individuals with AR 6
• The population attributable fraction ranges from 6.8-18.1%, meaning a meaningful proportion of migraine cases in the population may be attributable to AR 6

However, no Mendelian randomization studies have established a causal relationship between rhinitis and migraine. The association may be bidirectional or mediated through shared inflammatory pathways, sleep disruption, or other mechanisms.

Mechanistic Pathways

OSA → Migraine Mechanisms:

• Intermittent hypoxia during apneic episodes triggers oxidative stress and vascular changes
• Sleep fragmentation lowers migraine threshold and increases headache frequency
• Autonomic dysfunction from repetitive arousals affects pain modulation
• These mechanisms particularly affect migraine with aura, consistent with the causal evidence 1

Rhinitis → Migraine Mechanisms (Proposed):

• Inflammatory mediators from nasal mucosa may have systemic effects beyond local obstruction 7
• Sleep disruption from nasal obstruction causes lighter non-REM sleep and reduced REM sleep 7
• Increased upper airway resistance during sleep may worsen respiratory instability 7
• Rhinitis increases OSA risk (OR = 1.14), which then causally increases migraine risk—an indirect causal pathway 8

Clinical Algorithm for Evaluation

When evaluating a patient with migraine and suspected OSA/rhinitis:

1. Screen for OSA symptoms: Snoring, witnessed apneas, excessive daytime sleepiness (ESS score), morning headaches, unrefreshing sleep

   • Particularly important in patients with chronic migraine before starting CGRP antibodies 3
   • Higher suspicion if overweight/obese, neck circumference >17 inches (men) or >16 inches (women)

2. Assess rhinitis severity: NOSE scale scores correlate with respiratory instability markers during sleep 7

   • Perennial rhinitis shows 11% OSA prevalence vs 2.3% in controls 9
   • Both allergic and non-allergic rhinitis affect sleep quality 7

3. Order appropriate sleep studies:

   • Type I polysomnography remains gold standard for OSA diagnosis 10
   • Home sleep studies (Type III) acceptable for high pretest probability but higher false-negative rates 10

4. Treat identified conditions:

   • OSA: CPAP is first-line (strong recommendation, moderate-quality evidence) 11
   • Rhinitis with OSA: Intranasal corticosteroids reduce nasal airway resistance and apnea-hypopnea frequency 9, 5
   • Migraine prevention: Consider topiramate (evidence for chronic migraine), CGRP antibodies if multiple preventives fail 12, 13

Important Caveats

• The causal evidence for OSA → migraine is specific to migraine with aura, not migraine without aura or general migraine 1
• Rhinitis appears to increase migraine risk indirectly through increasing OSA risk rather than through direct causation 8
• The 2011 guideline states that drug therapy is not recommended as treatment for OSA itself (most drugs grade C evidence) 9
• Weight loss should be encouraged in all overweight/obese patients with OSA (strong recommendation) 11
• Medication overuse headache must be ruled out in chronic migraine before attributing symptoms to OSA/rhinitis 12, 14

Summary of Evidence Quality

The strongest causal evidence comes from the 2025 Mendelian randomization study showing OSA causes migraine with aura 1. This is supported by large observational cohorts 2 and recognized in clinical guidelines 4, 5. For rhinitis, the evidence remains associative 6, though mechanistic studies suggest sleep disruption and inflammation as plausible pathways 7. The clinical recommendation is clear: screen for and treat OSA in patients with chronic migraine, as this addresses a modifiable risk factor with established causal evidence.